WEBVTT 1 00:00:00.000 --> 00:00:02.580 We take a digital-first approach, 2 00:00:02.580 --> 00:00:05.520 challenging ourselves to create products, capabilities, 3 00:00:05.520 --> 00:00:09.180 and insights that are positively disruptive 4 00:00:09.180 --> 00:00:10.772 or raise the standard of care. 5 00:00:10.772 --> 00:00:13.439 (lively music) 6 00:00:17.370 --> 00:00:20.280 I'm delighted to welcome Lidia Fonseca, 7 00:00:20.280 --> 00:00:21.870 Executive Vice President 8 00:00:21.870 --> 00:00:24.300 and Chief Digital and Technology Officer 9 00:00:24.300 --> 00:00:26.343 at Pfizer since 2019. 10 00:00:28.290 --> 00:00:31.170 Lidia, welcome, and thank you for joining me. 11 00:00:31.170 --> 00:00:34.320 Tell us about Pfizer's bold digital transformation 12 00:00:34.320 --> 00:00:35.580 a little more. 13 00:00:35.580 --> 00:00:36.720 First, we lead 14 00:00:36.720 --> 00:00:40.230 with the experience we're trying to create 15 00:00:40.230 --> 00:00:43.943 for patients, physicians, payers, regulators, 16 00:00:43.943 --> 00:00:46.110 and our own colleagues. 17 00:00:46.110 --> 00:00:49.440 Second, we take a digital-first approach, 18 00:00:49.440 --> 00:00:52.350 challenging ourselves to create products, capabilities, 19 00:00:52.350 --> 00:00:56.040 and insights that are positively disruptive 20 00:00:56.040 --> 00:00:58.560 or raise the standard of care. 21 00:00:58.560 --> 00:01:00.870 Third, we bring digital innovation 22 00:01:00.870 --> 00:01:04.560 across our entire value chain horizontally 23 00:01:04.560 --> 00:01:07.380 so that we can achieve maximum impact. 24 00:01:07.380 --> 00:01:09.690 We're driving end-to-end innovation 25 00:01:09.690 --> 00:01:12.720 with three strategic priorities in mind: 26 00:01:12.720 --> 00:01:15.090 to improve patient health outcomes, 27 00:01:15.090 --> 00:01:17.292 to bring medicines to patients faster, 28 00:01:17.292 --> 00:01:19.770 and fuel tomorrow's breakthrough therapies, 29 00:01:19.770 --> 00:01:22.320 starting with research and discovery, 30 00:01:22.320 --> 00:01:25.080 where supercomputing capabilities 31 00:01:25.080 --> 00:01:28.650 with AI and machine learning are helping our scientists 32 00:01:28.650 --> 00:01:32.550 accelerate compounds through discovery to development. 33 00:01:32.550 --> 00:01:35.280 We leverage virtual in silico screening, 34 00:01:35.280 --> 00:01:38.400 which refers to sophisticated computational modeling 35 00:01:38.400 --> 00:01:40.380 and simulation techniques 36 00:01:40.380 --> 00:01:43.350 that test molecular compounds in a virtual lab. 37 00:01:43.350 --> 00:01:48.350 This capability reduces computational times by 80 to 90%, 38 00:01:48.930 --> 00:01:51.870 quickly narrowing down to only those compounds 39 00:01:51.870 --> 00:01:54.930 with the highest chance of becoming the medicine we need. 40 00:01:54.930 --> 00:01:58.083 How do we leverage digital data and AI 41 00:01:59.106 --> 00:02:03.330 and how this program has accelerated your purpose 42 00:02:03.330 --> 00:02:06.000 and what the biggest wins are so far? 43 00:02:06.000 --> 00:02:09.570 We're also using generative AI modeling 44 00:02:09.570 --> 00:02:14.010 to design entirely new molecules with optimal activity, 45 00:02:14.010 --> 00:02:15.810 searching beyond known molecules 46 00:02:15.810 --> 00:02:19.080 to propose entirely new chemical structures. 47 00:02:19.080 --> 00:02:20.730 In clinical development, 48 00:02:20.730 --> 00:02:23.010 digital brings the trial to the participant 49 00:02:23.010 --> 00:02:24.690 through remote trials, 50 00:02:24.690 --> 00:02:27.810 helping boost recruitment, retention, and diversity 51 00:02:27.810 --> 00:02:31.020 while elevating the participant experience. 52 00:02:31.020 --> 00:02:34.140 AI and machine learning are enabling our teams 53 00:02:34.140 --> 00:02:35.760 to perform quality checks 54 00:02:35.760 --> 00:02:39.090 and analyze vast amounts of clinical trial data 55 00:02:39.090 --> 00:02:42.090 50% faster than prior methods. 56 00:02:42.090 --> 00:02:43.800 Over on the manufacturing front, 57 00:02:43.800 --> 00:02:46.635 our patent-pending Digital Operations Center 58 00:02:46.635 --> 00:02:50.670 provides an end-to-end view of manufacturing and supply. 59 00:02:50.670 --> 00:02:53.040 This allows the team to predict issues 60 00:02:53.040 --> 00:02:54.810 and adjust in real time 61 00:02:54.810 --> 00:02:57.663 and has yielded 20% increase in throughput.